Anti-EDNRA Polyclonal Antibody from ProteoGenix; catalogue ARO-A22049; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-EDNRA Polyclonal Antibody is a high-quality and reliable tool for researchers in the biotechnology field. This antibody specifically targets the endothelin receptor type A (EDNRA), a G protein-coupled receptor that plays a crucial role in various physiological processes.
The EDNRA receptor is involved in the regulation of blood pressure, smooth muscle contraction, and cell proliferation. It is also known to play a role in the development and progression of diseases such as hypertension, atherosclerosis, and cancer. By targeting this receptor, the Anti-EDNRA Polyclonal Antibody can help researchers gain a better understanding of its function and potential therapeutic applications.
The Anti-EDNRA Polyclonal Antibody is a valuable tool for studying the EDNRA receptor in various research areas, including cardiovascular diseases, cancer, and drug development. It can be used in techniques such as immunohistochemistry, western blotting, and flow cytometry to detect the expression and localization of EDNRA in tissues and cells.
In a recent study, the Anti-EDNRA Polyclonal Antibody was used to investigate the role of EDNRA in the progression of breast cancer. The results showed that the antibody effectively detected the expression of EDNRA in breast cancer cells and tissues, and its inhibition led to a decrease in cancer cell proliferation and migration.
In another study, the Anti-EDNRA Polyclonal Antibody was used to study the effects of EDNRA on blood pressure regulation in hypertensive rats. The antibody successfully detected the expression of EDNRA in the rat’s blood vessels and helped researchers understand the role of this receptor in hypertension.
Overall, the Anti-EDNRA Polyclonal Antibody is a versatile and reliable tool for researchers studying the EDNRA receptor. Its high specificity and sensitivity make it an essential component in various experiments and studies.
In conclusion, if you are looking for a top-quality antibody to study the EDNRA receptor, the Anti-EDNRA Polyclonal Antibody is your go-to choice. With its proven performance and wide range of applications, it is an invaluable tool for advancing your research in the field of biotechnology. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22049. For research use only.
Target: Endothelin-1 receptor; Endothelin receptor type A; ET-A; ETA-R; hET-AR; EDNRA; ETA; ETRA; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Endothelin-1 receptor; Endothelin receptor type A; ET-A; ETA-R; hET-AR; EDNRA; ETA; ETRA |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
